| Apogee Therapeutics, Inc. | 5,323 | US$707K | 1.4% |
| Moderna, Inc. | 9,574 | US$670K | 1.4% |
| Twist Bioscience Corporation | 6,497 | US$668K | 1.4% |
| Oruka Therapeutics, Inc. | 6,876 | US$654K | 1.3% |
| Kymera Therapeutics, Inc. | 5,628 | US$645K | 1.3% |
| Viking Therapeutics, Inc. | 15,866 | US$619K | 1.3% |
| Praxis Precision Medicines, Inc. | 1,830 | US$613K | 1.3% |
| Erasca, Inc. | 32,931 | US$603K | 1.2% |
| Revolution Medicines, Inc. | 3,054 | US$572K | 1.2% |
| Rhythm Pharmaceuticals, Inc. | 5,137 | US$570K | 1.2% |
| Cg Oncology, Inc. | 8,017 | US$570K | 1.2% |
| Sellas Life Sciences Group, Inc. | 38,263 | US$565K | 1.2% |
| Vaxcyte, Inc. | 9,694 | US$564K | 1.2% |
| Dianthus Therapeutics, Inc. | 5,761 | US$562K | 1.2% |
| Cytokinetics, Incorporated | 6,565 | US$559K | 1.1% |
| Natera, Inc. | 2,034 | US$552K | 1.1% |
| Scholar Rock Holding Corporation | 9,986 | US$549K | 1.1% |
| Roivant Sciences Ltd. | 15,498 | US$548K | 1.1% |
| Mirum Pharmaceuticals, Inc. | 4,684 | US$548K | 1.1% |
| Cogent Biosciences, Inc. | 14,031 | US$543K | 1.1% |
| Ultragenyx Pharmaceutical Inc. | 16,214 | US$541K | 1.1% |
| Travere Therapeutics, Inc. | 9,420 | US$535K | 1.1% |
| Alkermes Plc | 10,043 | US$526K | 1.1% |
| Krystal Biotech, Inc. | 1,409 | US$524K | 1.1% |
| Celcuity Inc. | 4,990 | US$522K | 1.1% |
| Relay Therapeutics, Inc. | 27,879 | US$522K | 1.1% |
| Spyre Therapeutics, Inc. | 5,864 | US$521K | 1.1% |
| Tg Therapeutics, Inc. | 9,448 | US$519K | 1.1% |
| Beam Therapeutics Inc. | 14,930 | US$512K | 1.0% |
| Protagonist Therapeutics, Inc. | 4,163 | US$510K | 1.0% |
| Insmed Incorporated | 4,786 | US$510K | 1.0% |
| Arrowhead Pharmaceuticals, Inc. | 6,225 | US$507K | 1.0% |
| Vera Therapeutics, Inc. | 11,718 | US$503K | 1.0% |
| Vertex Pharmaceuticals Incorporated | 1,011 | US$502K | 1.0% |
| Madrigal Pharmaceuticals, Inc. | 934 | US$502K | 1.0% |
| Abbvie Inc. | 1,957 | US$492K | 1.0% |
| Biogen Inc. | 2,267 | US$490K | 1.0% |
| Ptc Therapeutics, Inc. | 6,003 | US$490K | 1.0% |
| Halozyme Therapeutics, Inc. | 6,245 | US$489K | 1.0% |
| Uniqure N.v. | 10,597 | US$488K | 1.00% |
| Bridgebio Pharma, Inc. | 6,532 | US$487K | 1.00% |
| Crispr Therapeutics Ag | 8,906 | US$486K | 1.00% |
| Immunitybio, Inc. | 55,254 | US$484K | 0.99% |
| Summit Therapeutics Inc. | 32,957 | US$480K | 0.98% |
| Ionis Pharmaceuticals, Inc. | 6,005 | US$476K | 0.98% |
| Incyte Corporation | 4,178 | US$474K | 0.97% |
| Amgen Inc. | 1,304 | US$472K | 0.97% |
| Neurocrine Biosciences, Inc. | 2,737 | US$461K | 0.94% |
| Gilead Sciences, Inc. | 3,624 | US$458K | 0.94% |
| Regeneron Pharmaceuticals, Inc. | 732 | US$456K | 0.94% |
| Exelixis, Inc. | 8,374 | US$456K | 0.93% |
| Alnylam Pharmaceuticals, Inc. | 1,512 | US$455K | 0.93% |
| Biomarin Pharmaceutical Inc. | 7,839 | US$449K | 0.92% |
| Acadia Pharmaceuticals Inc. | 17,586 | US$445K | 0.91% |
| Nuvalent, Inc. | 3,569 | US$441K | 0.90% |
| Immunovant, Inc. | 11,393 | US$439K | 0.90% |
| United Therapeutics Corporation | 809 | US$438K | 0.90% |
| Intellia Therapeutics, Inc. | 25,453 | US$431K | 0.88% |
| Grail, Inc. | 6,303 | US$430K | 0.88% |
| Biocryst Pharmaceuticals, Inc. | 42,367 | US$424K | 0.87% |
| Catalyst Pharmaceuticals, Inc. | 13,200 | US$415K | 0.85% |
| Dyne Therapeutics, Inc. | 18,359 | US$408K | 0.84% |
| Tango Therapeutics, Inc. | 12,783 | US$400K | 0.82% |
| Denali Therapeutics Inc. | 15,367 | US$395K | 0.81% |
| Veracyte, Inc. | 6,617 | US$389K | 0.80% |
| Ideaya Biosciences, Inc. | 10,232 | US$381K | 0.78% |
| Recursion Pharmaceuticals, Inc. | 97,873 | US$359K | 0.74% |
| Sarepta Therapeutics, Inc. | 19,723 | US$354K | 0.73% |
| Arcus Biosciences, Inc. | 11,440 | US$353K | 0.72% |
| Syndax Pharmaceuticals, Inc. | 15,597 | US$341K | 0.70% |
| Arcutis Biotherapeutics, Inc. | 12,884 | US$338K | 0.69% |
| Mineralys Therapeutics, Inc. | 12,471 | US$336K | 0.69% |
| Celldex Therapeutics, Inc. | 8,957 | US$333K | 0.68% |
| Agios Pharmaceuticals, Inc. | 8,865 | US$329K | 0.67% |
| Viridian Therapeutics, Inc. | 17,346 | US$319K | 0.65% |
| Novavax, Inc. | 33,288 | US$314K | 0.64% |
| Disc Medicine, Inc. | 4,238 | US$310K | 0.63% |
| Adma Biologics Inc | 34,452 | US$288K | 0.59% |
| Immunome, Inc. | 13,266 | US$281K | 0.58% |
| Palvella Therapeutics, Inc. | 1,812 | US$277K | 0.57% |
| Iovance Biotherapeutics, Inc. | 64,260 | US$267K | 0.55% |
| Absci Corporation | 22,928 | US$266K | 0.54% |
| Nurix Therapeutics, Inc. | 10,904 | US$265K | 0.54% |
| Kodiak Sciences Inc | 6,630 | US$258K | 0.53% |
| Biohaven Ltd. | 16,808 | US$250K | 0.51% |
| Vericel Corporation | 5,295 | US$236K | 0.48% |
| Anaptysbio, Inc. | 3,487 | US$235K | 0.48% |
| Capricor Therapeutics, Inc. | 9,630 | US$232K | 0.48% |
| Stoke Therapeutics, Inc. | 6,977 | US$228K | 0.47% |
| Monte Rosa Therapeutics, Inc. | 9,372 | US$227K | 0.46% |
| Vir Biotechnology, Inc. | 21,927 | US$223K | 0.46% |
| Hyperliquid Strategies Inc | 28,063 | US$221K | 0.45% |
| Tyra Biosciences, Inc. | 6,173 | US$197K | 0.40% |
| Corvus Pharmaceuticals, Inc. | 12,998 | US$194K | 0.40% |
| Cullinan Therapeutics, Inc. | 10,542 | US$192K | 0.39% |
| Precigen, Inc. | 31,415 | US$179K | 0.37% |
| Inhibrx Biosciences, Inc. | 1,778 | US$168K | 0.35% |
| Taysha Gene Therapies, Inc. | 24,676 | US$168K | 0.34% |
| Ardelyx, Inc. | 32,884 | US$168K | 0.34% |
| Avalo Therapeutics, Inc. | 8,998 | US$166K | 0.34% |